Ramadan Karrout
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ramadan Karrout has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Avinash Naraiah Mukkala
Keenan Research Centre for Biomedical Science, Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Unity Health Toronto, Toronto, ON, Canada
1 shared publicationCatherine Parmentier
Ajmera Transplant Centre, Toronto General Hospital, University Health Network, Toronto, ON, Canada
1 shared publication- Christian Hobeika
Department of HPB Surgery and Liver Transplantation, Beaujon Hospital, APHP, Clichy, Paris-Cité University, Paris, France
1 shared publication Cindy Lin
Ajmera Transplant Centre, Toronto General Hospital, University Health Network, Toronto, ON, Canada
1 shared publicationEmma Mizdrak
Ajmera Transplant Centre, Toronto General Hospital, University Health Network, Toronto, ON, Canada
1 shared publication- Eno Hysi
Ryerson University
1 shared publication
Latest Publications
- 25 June 2025
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 282 (3) , 389-400
Mitochondrial Transplantation Reduces Injury and Improves Liver Function in a Porcine Model of Hemi-hepatic Ischemia/Reperfusion
Objective: To assess mitochondrial transplantation (MitoTx) via portal vein infusion to reduce liver ischemia-reperfusion injury (I/R) in a survival porcine model. Summary Background Data: MitoTx has been shown to alleviate I/R injury in various organs. Methods: Male Yorkshire pigs (38±1 kg) were subjected to 2 hours of ischemia in the left hemi-liver (left portal-triad clamping), and at the beginning of reperfusion (marked as t=0 h), animals received a 1-hour infusion of autologous mitochondria (MT, 7×10^9/kg) or saline (controls) via the portal vein. Liver tissue oxygen saturation (sO2) was assessed by photoacoustic imaging. Results: Twelve pigs (6 MitoTx vs. 6 controls) underwent 2-hour left hemi-liver I/R. All pigs recovered and were ambulatory at t=6 hours. MitoTx reduced peak AST levels at t=2 hours compared with controls (299.83±46.62 vs. 878.83±255.09 UI/L; P=0.049). At t=24 hours, MitoTx pigs had lowered necrosis area percentage (8.01±4.12 vs. 23.40±7.33 %; P=0.08) in left livers—all right lobes had 0% necrotic area. MitoTx pigs had shorter prothrombin time, plateauing around t=8 hours (12.9±0.3 vs. 14.1±0.1 s; P=0.003), faster lactate clearance (P=0.003] and from the bile [HR: 1.4, (1.1, 1.7); P=0.009] compared with controls. At t=6 hours, MitoTx pigs had decreased IL-6 (304±71 vs. 686±87 pg/mL; P=0.007). Photoacoustic imaging showed that MitoTx pigs had a better recovery of sO2 from baseline in left livers compared with controls (at t=30 min; −3.05±2.72 vs. −15.19±2.92 %; P=0.016). Conclusion: MitoTx reduces injury and improves liver function after prolonged liver I/R, showing promise for liver transplantation.
- 25 June 2025
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 282 (3) , 389-400
Mitochondrial Transplantation Reduces Injury and Improves Liver Function in a Porcine Model of Hemi-hepatic Ischemia/Reperfusion
Objective: To assess mitochondrial transplantation (MitoTx) via portal vein infusion to reduce liver ischemia-reperfusion injury (I/R) in a survival porcine model. Summary Background Data: MitoTx has been shown to alleviate I/R injury in various organs. Methods: Male Yorkshire pigs (38±1 kg) were subjected to 2 hours of ischemia in the left hemi-liver (left portal-triad clamping), and at the beginning of reperfusion (marked as t=0 h), animals received a 1-hour infusion of autologous mitochondria (MT, 7×10^9/kg) or saline (controls) via the portal vein. Liver tissue oxygen saturation (sO2) was assessed by photoacoustic imaging. Results: Twelve pigs (6 MitoTx vs. 6 controls) underwent 2-hour left hemi-liver I/R. All pigs recovered and were ambulatory at t=6 hours. MitoTx reduced peak AST levels at t=2 hours compared with controls (299.83±46.62 vs. 878.83±255.09 UI/L; P=0.049). At t=24 hours, MitoTx pigs had lowered necrosis area percentage (8.01±4.12 vs. 23.40±7.33 %; P=0.08) in left livers—all right lobes had 0% necrotic area. MitoTx pigs had shorter prothrombin time, plateauing around t=8 hours (12.9±0.3 vs. 14.1±0.1 s; P=0.003), faster lactate clearance (P=0.003] and from the bile [HR: 1.4, (1.1, 1.7); P=0.009] compared with controls. At t=6 hours, MitoTx pigs had decreased IL-6 (304±71 vs. 686±87 pg/mL; P=0.007). Photoacoustic imaging showed that MitoTx pigs had a better recovery of sO2 from baseline in left livers compared with controls (at t=30 min; −3.05±2.72 vs. −15.19±2.92 %; P=0.016). Conclusion: MitoTx reduces injury and improves liver function after prolonged liver I/R, showing promise for liver transplantation.